Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ready-to-use Dasiglucagon for the Treatment of Postprandial Hypoglycaemia in Roux-en-Y Gastric Bypass Operated Patients

NCT04836273 is registered in ClinicalTrials.gov with Filip Krag Knop as lead sponsor.

NCT NCT04836273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04836273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ready-to-use Dasiglucagon for the Treatment of Postprandial Hypoglycaemia in Roux-en-Y Gastric Bypass Operated Patients
Lead sponsor
Filip Krag Knop
Phase
Phase 2
Overall status
Completed
Start date
August 20, 2021
Completion date
December 15, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinemic hypoglycemia, postprandial hypoglycemia